60 related articles for article (PubMed ID: 37970615)
41. Risk factors for erysipelas of the leg (cellulitis): case-control study.
Dupuy A; Benchikhi H; Roujeau JC; Bernard P; Vaillant L; Chosidow O; Sassolas B; Guillaume JC; Grob JJ; Bastuji-Garin S
BMJ; 1999 Jun; 318(7198):1591-4. PubMed ID: 10364117
[TBL] [Abstract][Full Text] [Related]
42. Histomorphometric study of portal hypertensive enteropathy.
Misra V; Misra SP; Dwivedi M; Gupta SC
Am J Clin Pathol; 1997 Dec; 108(6):652-7. PubMed ID: 9384446
[TBL] [Abstract][Full Text] [Related]
43. Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis.
Vollmar B; Wolf B; Siegmund S; Katsen AD; Menger MD
Am J Pathol; 1997 Jul; 151(1):169-75. PubMed ID: 9212743
[TBL] [Abstract][Full Text] [Related]
44. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat.
Barrowman JA; Granger DN
Gastroenterology; 1984 Jul; 87(1):165-72. PubMed ID: 6724260
[TBL] [Abstract][Full Text] [Related]
45. Lymphoedema: pathophysiology and classification.
Browse NL; Stewart G
J Cardiovasc Surg (Torino); 1985; 26(2):91-106. PubMed ID: 3884629
[TBL] [Abstract][Full Text] [Related]
46. Lymphatic pathways and role of valves in lymph propulsion from small intestine.
Unthank JL; Bohlen HG
Am J Physiol; 1988 Mar; 254(3 Pt 1):G389-98. PubMed ID: 3348405
[TBL] [Abstract][Full Text] [Related]
47. Chylous ascites in cirrhosis: a case report and review of the literature.
Cheng WS; Gough IR; Ward M; Croese J; Powell LW
J Gastroenterol Hepatol; 1989; 4(1):95-9. PubMed ID: 2490947
[TBL] [Abstract][Full Text] [Related]
48. Increased lymphatic flow from the liver in different intra- and extrahepatic diseases demonstrated by CT.
Aspestrand F; Schrumpf E; Jacobsen M; Hanssen L; Endresen K
J Comput Assist Tomogr; 1991; 15(4):550-4. PubMed ID: 2061465
[TBL] [Abstract][Full Text] [Related]
49. Primary intestinal lymphangiectasia (Waldmann's disease).
Vignes S; Bellanger J
Orphanet J Rare Dis; 2008 Feb; 3():5. PubMed ID: 18294365
[TBL] [Abstract][Full Text] [Related]
50. Revisiting the gut-liver axis: gut lymphatic system in liver cirrhosis and portal hypertension.
Juneja P; Tripathi DM; Kaur S
Am J Physiol Gastrointest Liver Physiol; 2022 May; 322(5):G473-G479. PubMed ID: 35195034
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism.
Arya R; Kumar R; Kumar T; Kumar S; Anand U; Priyadarshi RN; Maji T
World J Hepatol; 2023 Oct; 15(10):1140-1152. PubMed ID: 37970615
[TBL] [Abstract][Full Text] [Related]
52. Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.
Kumar R; Anand U; Priyadarshi RN
World J Hepatol; 2021 Mar; 13(3):300-314. PubMed ID: 33815674
[TBL] [Abstract][Full Text] [Related]
53. Primary intestinal lymphangiectasia presenting as limb hemihyperplasia: a case report and literature review.
Khayat AA
BMC Gastroenterol; 2021 May; 21(1):225. PubMed ID: 34006223
[TBL] [Abstract][Full Text] [Related]
54. Review article: the diagnostic approach and current management of chylous ascites.
Lizaola B; Bonder A; Trivedi HD; Tapper EB; Cardenas A
Aliment Pharmacol Ther; 2017 Nov; 46(9):816-824. PubMed ID: 28892178
[TBL] [Abstract][Full Text] [Related]
55. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.
Bhardwaj R; Vaziri H; Gautam A; Ballesteros E; Karimeddini D; Wu GY
J Clin Transl Hepatol; 2018 Mar; 6(1):105-113. PubMed ID: 29577037
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
